Begrivac

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug; Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug

Disponible desde:

Novartis New Zealand Ltd

Designación común internacional (DCI):

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg

Dosis:

0.5 mL

formulario farmacéutico:

Suspension for injection

Composición:

Active: Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug Excipient: Ether Formaldehyde Phosphate Buffered Saline Polymyxin B Polysorbate 80 Sucrose

Unidades en paquete:

Syringe, glass, Prefilled single 0.5ml dose, 1 dose unit

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

GSK Vaccines GmbH

Resumen del producto:

Package - Contents - Shelf Life: Syringe, glass, Prefilled single 0.5ml dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 0.5mL syringe, 10 pack - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Fecha de autorización:

1999-11-12